lapatinib ditosylate monohydrate

Poland

Drugs containing this active substance

  • BRASTBI

    The medicine is used to treat certain types of advanced or metastatic breast cancer (with HER2 receptor overexpression). It is administered in combination with other anticancer medicines.

    Form: tablets, film-coated

    Active substance Dosage
    lapatinib ditosylate monohydrate 405 mg

    ATC: L01EH01

    Manufacturer: PharOS Mt Ltd Remedica Ltd STADA Arzneimittel AG